Expertise in
2
conditions

Henri Janicot

Clermont-ferrand, FR 
Expertise in
2
conditions
Clermont-ferrand, FR 

Overview

Henri Janicot practices practicing medicine in Clermont-ferrand, France.

Janicot is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

They are actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 1 clinical trial.

Locations

Clermont-ferrand, 63000, France
Other Locations
Toulouse, France
Creteil, France
CHU Pontchaillou
Rennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer
Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drugs: AZD2014, AZD4547, AZD5363, AZD8931, Selumetinib, Vandetanib, Standard Maintenance, Pemetrexed, Durvalumab, Savolitinib, Olaparib
Study Phase: Phase 2

16 Total Publications

Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker.
Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker.
Journal: Cancers
Published: November 30, 2022

Frequently Asked Questions about Henri Janicot

Is Henri Janicot a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Henri Janicot is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Henri Janicot participate in research or clinical trials?

Yes. Henri Janicot has published 16 articles and abstracts on conditions like Lung Cancer. You can view a list of Henri Janicot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Janicot's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile